Marking World Alzheimer’s Day: Advancing the Fight Against Tauopathies
On World Alzheimer’s Day, Glyx Therapeutics joins the global scientific community in recognizing the collective commitment to developing therapeutic solutions for tauopathies, including Pick’s disease, rare dementias, and Alzheimer’s disease. This day underscores the scale of the challenge these neurodegenerative disorders present and the shared determination to overcome it.
